StockGlow

GSK plc (GSKL.XC)

GSK plc, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

1,936.00-0.03%Healthcare
Compare GSKL.XC with
StockGlow Score
55
Neutral
BearishBullish
1 year ago+38.2%

The outlook

GSK plc currently reads as neutral based on mixed vs its moving averages, 62% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range62% of the way from its 52-week low to high
Market cap
$77.72B
52-wk high
2,282.00
52-wk low
1,361.00
50-day avg
1,939.34
200-day avg
1,935.35
Trailing P/E
1640.7

Similar stocks

BPL.XCBP p.l.c.$540.70-0.84%HSBAL.XCHSBC Holdings plc$1,586.20+2.55%DGEL.XCDiageo plc$1,638.00-1.19%SHELL.XCShell plc$3,320.00-0.14%RELL.XCRELX PLC$2,680.00-6.59%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy